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MI us controls. For HindIll, lho homorygola (~ 1” ) froquonoy 0160 wns nal 
inorensod In MI (0.7% OR _ 1 ,l) cr CAD pl (8.31, OR 9 O.fS). 
Conclusron: Common LPL polvmarphmma nro not nssoclntod wcth lnrgo 
lncreasos tn nsk (OR 1 1,s) for CAD or MI. Howovor, smallor ovemll risk. 
or rxlbgroup apoc~kc nskR (~a, In woman), nro nal excluded. nnd should bo 
furlher avnlunlad. 
P, Rodrlgu@8, M, do Lurdaa Andmda, .I. Coucele, J. Amvodo, M,I, Porelrn. 
I, Arrojn, T. Vax, I. Oil, 0, Sl\vn, 8, lXmr\a, V. Amu)o, L. Guermmx M dn 
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The rolnllanahlp bnlwoon nlhorognnanla nnd lhrombagonc~slri IA wall oslnb, 
llahod and wldnly roconnlrod. Tho plnsmn loval al Ilpoprolain (n) - Lp(a) . 
hnl w dlrecl lnvolvomanl an lha pnlhophyalullrgy al coronnry orlary dlaonso 
(CAD). lhmuah 118 dunl mlo OR n lrnn8porl nnd lnlorncllon pnrlcclo an lhn 
andolhallnl wall. Wo as#umo lhnl lha hlghor tha plnnmn lavol ol Lp(o) nnd 
amnllar lhs moloculnr shucluro ol npoprololn (n) . Ape (a), more aoatly Cp(n) 
cnn axpmsla IIR pnthaQania atlaot. IAO Lp(a) wnn avnktdnd III a papulnhon al 
43 pin wllh cllnlcnl dlo6nnnls ol CAD, maan ago 7hR 1 II yta (!iB-HI yes), 40% 
mnlw gondor. dlvldod nccardlng lo lnoronwng dogroan at CCS clnstxltanhon 
snd thapmnnnco olocalo myocnrdiol Inlnmllon (AMI) Alhomllonlc lp(o) VW 
Idbnllflad, gsnollcnlly dobxmlnod wilh aavaral I8omorphlc fatma - lso Lp(n) 
. whloh warn dallnad m tormn 01 lho mimbor ol knnglos. I8olp(a) can bo 
dlvlded In lwa groupw, dopandlng on ila dlmanslona nnd ponolrnbng co+xl!y 
01 lhn ondalhelinl wnll. laoLp(n) wllh rmnll dlmonslona (Qroup I; n a 20 pls) 
. IloLp(a) p, B, 81 nnd S2. mpmsonl Iho parllclaa wtlh highor ponolraling 
CapnClly ‘n mu &xlnl wnll. whllo tha laoLp(n) wllh gronlor dlmonstons and 
IawQr pnnolmling cnpnclly . laoLp(o) S3. SO nnd S 4 . wow included In 
the rocond (amup (Qroup II: n m 23 pla). laoLp(n) nm doloclod by spocd~c 
and highly Roloc1lvo blochomlcnl tochnlqua lollawod by tmrnunoblo~llng and 
nnzymallc dofacllon Totnl Choloshxol (Chol), LP rich In Chol (LDL. HDL. 
HDl-2). Lp(a) nnd nn~l.phosphollpld nn\l.bodias (APA) warn do\ormmod. 
Tho Isomorphic spoclas In c~rculnhng Lp(n) wllh small dlmensmns h~vo 
a htighor nlhorogorvc polonhnl IhOl IS cllroclly rolnlod wllh 11s ponolralmg 
cnpnclty nnd nccurnulnllon wllhm Iho nrl@nal wnll. Paltenls wllh more sovero 
clinical oxpross~on 01 CAD hnvo mom lroqucnt small Isomorphtc Apo (a) 
and lhls could have palho-physlologtc Impllcaltons m lho progrosslon and 
growing ot Inlra-coronnry nlharomdous los1ons 
1065-14 Human Qaraoxwase (PONA) Qenotype 
Determlnes the Susceptlblllty to Oxldatlon of 
High-Density Llpoproteln (HDL) Particle 
Y. Walnnnbo. H. Ohmurn. M. Snwano. Ii Mokuno. Ii Daida. Ii Yamaguchl. 
Junfendo Ufl~vrrs~fy Tbkyo, Japan 
t3ackground~ PONA IS a HDL nssoclaled enzyme thal hydrolyze organphos- 
phales. carboxyllc acids osler. and carbamnlo. Recently the assoclallon 01 
coronary attory dlsonse (CAD) and PONA achvlty woro reported. and PONA 
genolype IS consldemd as a new coronary nsk factor. In lhls study we inves- 
hgated lho PONA genotype and suscopllblltly lo ouldallon of kpoprotems lo 
elucidate the contnbulion of PONA to alherosclerosls 
Mefhods: We analyzed 134 pahonls who underwent coronary anglogra- 
phy in our hospllnl. DNA were obtained from patients blood and PCR-RFLP 
methods were used lo determine the GlnlArg polymorphfsm 01 PONA. Gcno- 
type frequency ot AJA, A/B, B/B were 26 9%. 35.1?,. 38.1%. respectively. 
L!poprotelns were obtained lrom pahenls al least 12 hours fastmg and were 
separated with soquontlal ullracenlilugalion. We analyzed TBARS and the 
conhnuous momlonng 01 copper Induced oxidallon using 5 ,iM CuSO4 and 
100 rtg pmleln of each llpoprotems al 37C among the groups of three geno- 
typo. 
&%ulfs: TEARS levels ol plasma. VLDL. nnd LDL did not differ among 
the groups. but HDL TEARS were significantly higher in A/A than A/E or B/B 
(1.013. 0.616. 0.562 nM MDA/mg protein, p = 0.014). In A/A, LDL lag-hme 
was slightly shorter than A/B or 818 (43.2. 46.6. 46.0 min., p = 0.051). also 
HDL lag-lime was significantly shorter than A/B or B/B (16.4, 21.9.20.1 mm., 
P = 0.005) There was no ditference 01 CAD prevalence among the groups 
(A/A = 7S0.. AIE = 74O,. BIB = ES%). 
JACC’ . I;chnl;~n IVOX 
Conckfsion: PONA gonolype clonrly delermmed the axrdnkvo modilicnlton 
al HDL pnnlclo. Although wa lnllad IQ conlirm the assooielion of PONA germ 
lypo nnd CAD In the prosonl oludy, PONA mny plny a role In pnthogenasls 
al nlharosclarosir via HDL oxidnlion, 
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&dgmun@ In twmo provim~s ahidies, sevsrnl rosttickon fmgmenl longlh 
polymorphisms (RFLP8) in Iba lrpopmloin kpnsa (LPI.) gene were nrrsocialod 
wilh camnnry adory disenno (GAD) and plasma lIpid lavsk Rut it 18 bsa 
clonrty nslbkahed in Jopnnbso populaban. In thi8 r&!dy, we QUamiM?d Ihe 
dis~nbullon al the LPI. palymorphiams in a Jnpnneso population and the 
nnaocinllons bslwuen cl% polymorphisms (Hind III. Pvrr II) and CAD, plasma 
llpld lovols 
&fof))od? All pnlconle (n a 209, IOn males) wore undorwonl coronary 
nngiogmphy. CAD+ was dolmcd as .Sll% solnosts in nl @sl one ot mayor 
branch ot cnronnry nrlory (CAR+ = 146) Tho Hmd lll/Fvu II genotypas were 
nnnlyrod by 17CR RFLPa. 
Ff&sitlb’ Tho tmqwwioa PI Iho II2 and P2 alleles (“2” dcnolos presence 
ol cutlmg RIIQ) wore O.BO nnd 0.713. raspeclivo~y. Tha H2HP gwotypo was 
wgnilicnnlly more tmquonl in CAD+ lhan CAD (P . 001). The & II 
polymorphism showod no signikcan~ nssociallons wllh CAD H2H2 genotVpo 
nsaocinlod wilh slgnilicnn~ly lower levels ot HDL (P . 0.05) and Ape Al (P . 
0.05) thnn HlH2 + HlHl gonalypo. (43 t 16varsus 50 L 21 m@ll [mean 1 
SOl and lt2 i 23 vorw I22 t 2G mgtdl, respochvely). P2P2 geno~pe had 
nlso signileanlly lowor levels 01 HOL (P . 0.05) and Apo Al (P . 0.01) lhan 
PlP2tP2P2 gonolypo (43 t 1G versus 50 t 20 mgfdl and 112 t 22 velsus 
123 t 26 mgfdl, mspockvaly). Them were no other ass~~almns belween 
LPL RFlPs and olher kpoprolocn cumponenls 
Conclusrona- Tho rosulls ~uggoal lhal Hmd 111 polymorphism m the lP1 
gono contnbulos lo HDL cholostoml lovols and devclopmenl ol CAD 
( 1065-l 6 1 Recombinant Apollpoproteln A-Iuilam Protects 
Agalnst Lysophosphatldylcholine-induced 
Endothellal Dyafuncllon 
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We pmvtously demonshaled anllalherogenlc effects 01 reconsllluled htgh 
dens@ kpoprole~n IHDL) usmg Iho recombmanl apokpoprotem (ape) A-l mu- 
lnnl. ap~A.lu,~,~~, (ApoM). complexed with the phosphokpld tamer DMPC In 
lhls study. we examined whelhcr ApoM has any ellecls on lysophosphalldyl- 
cholmo (LPQ~mduced lmpalrmcnl 01 endothekum-dependent vasodllalalmn 
Rosponses lo acelylcholmo (1 rlM) were oxammed m camlld arlenes lmm 
15 normal rabbIIs perlused in uctro belorc and aker mcubalion wllh LPC (50 
JIM) m absence and presence 01 apoM and wlld.lype ape A-l (ApoWT) cam- 
ploxcd wilh DMPC. plasma-donved HDL. free apoM (F-ApoM) (all 1 mgfml) 
and Iho carnor DMPC (30 rtgjml). Changes m dlameler were measured. 
and responses were oxpressed as % change m ckameter (mean t SD) of 
proconslricled arlenes. Basellne dlamcler 01 carotid arlenes was 2.9 t 0 1 
mm. ‘p I 0.05 vorsus.LPC control. 
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LPC had no ellects on sodium mlroprusslde-mediated vasodllalahon. 
Conc/usron- Apo A-lk,,,a”O and apo A-l wild-type-reconsh~uled HDL as well 
as plasma-derived HDL. but not free apoM or the earner DMPC. slgmlicantly 
allonuatcd LPC-induced lmpalrment of endothekum-dependent vasodllala- 
11on. The proleclwe effects of apoM and apoWT were more pronounced than 
plasma HDL. Thus, reversal 01 endothellal dysfuncllon by HDL may. in part. 
explain the Inverse relatlonshlp between HDL choleslerol and coronary heart 
disease. 
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Background: Demonslratlon of a mutation in the LDL-receptor gene conhrms 
